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At present it is not possible to determine in advance the outcome of Leishmania infantum infection. Canine Visceral Leishmaniasis
(VL), caused by Le. infantum, is a natural disease process which oﬀers a insight into the interaction of the host and resultant
disease outcome. Canine VL results in the same altered pathophysiology and immunodysregulation seen in humans. VL in US
dogs is likely to be transmitted primarily via nontraditional, nonvector means. VL mediated by Le. infantum is endemic in U.S.
Foxhound dogs, with vertical transmission likely to be the novel primary means of transmission. This population of dogs oﬀers an
opportunity to identify host factors of natural disease. Prevention of human clinical visceral leishmaniasis can occur only by better
understanding the disease ecology of the primary reservoir host: the dog.
Copyright © 2009 Christine A. Petersen. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Leishmania infantum is the causative agent of visceral
leishmaniasis (VL) in the Mediterranean Basin and more
recently North America. Natural hosts include dogs and
humans [1], and transmission is usually via a sand ﬂy vector.
Infected dogs are the primary reservoir for zoonotic visceral
leishmaniasisinendemicregionsandarethemostsigniﬁcant
risk factor predisposing humans to infection [2]. Both dogs
and humans have a wide range of clinical presentation
due to infection with Le. infantum, ranging from asymp-
tomatic to fatal visceralizing disease (Figure 1). Host factors
which determine clinical outcome are poorly understood.
When clinical symptoms (signs) in both humans and dogs
occur, they include enlarged lymph nodes and hepato-
and splenomegaly due to parasitic invasion of the reticulo-
endothelial system of phagocytic lymphocytes [3]. Visceral
leishmaniasis symptoms persist in both humans and canine
patients for several weeks to months before patients seek
medical care. In the meanwhile these patients are at risk of
death from bacterial coinfections, massive bleeding, severe
anemia [3], or renal failure in veterinary patients. A better
understanding of this neglected disease, particularly the host
and vector factors which lead to disease transmission and/or
predict clinical outcome, is needed to optimally prevent
clinical disease outright but otherwise bring these patients to
medical attention faster, have them diagnosed correctly, and
treated successfully.
2. Transmission of Le. infantum
Dogs are the primary mammalian reservoir for Le. infantum
infection in endemic regions and are the most signiﬁcant
risk factor predisposing humans to infection [2]. In endemic
areas, the primary means of transmission is vector-borne via
the sand ﬂy. Canine infection in the US suggests a possible
human health threat if domestic sand ﬂy species are capable
of Leishmania transmission. Vector-borne transmission has
notbeenshownintheUStodate[4,5].Verticaltransmission
appears to be a major means of transmission in Foxhounds
in the US [4]. The frequency of vertical transmission
in endemic areas is unknown due to the overwhelming
likelihood of vector contact [6].2 Interdisciplinary Perspectives on Infectious Diseases
(a) (b)
Figure 1: Both humans and dogs have a wide clinical presentation with Le. infantum. These presentations vary from (a) no clinical signs and
robust healthy behavior in a young healthy Foxhound to (b) multiple clinical signs (polysymptomatic) including poor hair coat, enlarged
liver and spleen, and crusty cutaneous lesions seen on the rump in an older hound.
A potential sand ﬂy vector of Le. infantum, Lutzomyia
shannoni, is present within Southern and Southeastern
United States [4]. Lu. shannoni is known to bite dogs
and other mammals and has been incriminated in the
transmission of Le. brasiliensis in South and Central America
[7]. Anecdotal data indicate that US species of Lu. shannoni
can become infected with Le. infantum, but it is not known
whether these ﬂies permit Le. infantum development into
infectious metacyclic parasites. Vector feeding preferences
can importantly inﬂuence disease transmission. In the US,
Lu. shannoni has also been shown to bite dogs (Rowton
personal communication). Although vector feeding prefer-
ences can signiﬁcantly inﬂuence disease transmission, host
preferencefor Lu.shannoniinthe USis currentlynot known.
3. Sand Fly Preference for
CaninesasFoodSource
In South and Central America, several investigators have
demonstratedthatdogsareanimportantbloodsourcetothe
principal vector of visceral leishmaniasis: Lu. longipalpis [8,
9]. Data from a study of the emergence of visceral leishmani-
asis in Central Israel in the mid 1990’s [10] suggested that
a high prevalence of infected dogs (11.5%) contributed to
the onset of the disease in humans. In Brazil, Lu. longipalpis
is frequently found in houses with dogs [11]. A recent
study detected high levels of antisand ﬂy saliva antibodies in
dogs from an endemic area of transmission of Le. infantum
in Brazil compared to dogs from nonendemic areas [12],
suggesting high exposure to the visceral leishmaniasis vector
Lu. longipalpis. Dogs play a signiﬁcant role in the spread
and maintenance of Le. infantum in endemic areas, although
it is not completely clear why dogs are more attractive
as a blood source to sand ﬂies. Using the host selectivity
index, deﬁned as the number of sand ﬂies that feed on
a given host relative to the available biomass of the host
[13], Lu. pseudolongipalpis, a vector of visceral leishmaniasis
in Colombia, preferred dogs as blood source. In contrast,
Lu. longipalpis was shown to have no particular preference
for speciﬁc vertebrate hosts and to be opportunistic feeders
[14–17]. There has only been one substantial study looking
at the feeding preferences of Lu. shannoni in the US [18].
This study was performed on a largely uninhabited barrier
island oﬀ Georgia and did not ﬁnd dogs to be a primary
food source, but this was most likely because there were
very few dogs present on the island. In many settings dogs
have been shown to be a link between sylvatic and domestic
cycles of visceral leishmaniasis. Dogs often cross forest-
edge boundaries, thereby potentially bringing parasites to,
or from, sylvatic systems and to and from other potential
mammal hosts (such as foxes and opossums). In the US,
due to frequent exchange of Foxhounds between kennels
and these dogs’ penchant for spending time in the woods,
Foxhounds may be a primary focal point for transmission
of Le. infantum to sand ﬂies. Thus, if Lu. shannoni indeed
prefers to feed on dogs in comparison to other mammals,
infected dogs are more likely than other mammals to serve as
as o u r c eo fLe. infantum to an uninfected ﬂy. It is important
todeterminewhetherLu.shannonif eed so nd ogsan dfurthe r
if US sand ﬂies are permissive to parasite development into
infectious metacyclic promastigotes.
4. Visceral LeishmaniasisinFoxhounds
Visceral Leishmaniasis is classically transmitted to a suitable
mammalian host by the bite of an infected sand ﬂy after
which the promastigote form of the parasite is phagocytosed
by macrophages [1]. Although endemic in many parts of
the world, this disease has only recently been described as
transmitted solely within the US [19]. Previously, sporadic
cases have been reported in the United States, in human
and canine travelers returning to the US from endemic areas
[5]. However, in 2000, a kennel in New York State reported
four Foxhounds with no travel history to be infected with
Le. Infantum[19]. By 2005, 60 kennels in 22 states and two
Canadian provinces had reported seropositive Foxhounds
[20]. Nonvector-based mechanisms postulated for trans-
mission of canine visceral leishmaniasis in the US include
vertical transmission (transplacental or transmammary) and
horizontal transmission by direct contact with infected cells
in blood [4, 5, 21]. Transmission has been documented via
packed red blood cell transfusion from infected Foxhounds
[22]. It is not known how frequently vertical transmission
occurs naturally in endemic areas. There are reports ofInterdisciplinary Perspectives on Infectious Diseases 3
congenital transmission of visceral leishmaniasis in humans
and during experimental Leishmania infection of beagles
[20]. Pathology of visceral leishmaniasis of US Foxhounds
was equivalent to that seen in dogs and humans infected in
endemic areas through sand ﬂy transmission [21]. Whether
vertical transmission itself is solely responsible for the focus
of disease in this breed of dogs or whether there are genetic
factorspredisposing particular lineages of Foxhounds should
be further investigated.
5.DiagnosisofVisceral Leishmaniasis
In both humans and dogs, infection with Leishmania
infantum frequently does not equate with clinical illness.
The ratio of incident asymptomatic infection to incident
clinical cases varies with location, vector and parasite. Ratios
o f1 8 : 1i nB r a z i la n d5 0 : 1i nS p a i nh a v eb e e no b s e r v e d
in human populations [3] and is estimated to be 2:1 in
high-risk US Foxhounds. Diﬀerent means of transmission,
as observed in US Foxhounds, will also alter this ratio.
At present, diagnosis and control of visceral leishmaniasis
is diﬃcult as both humans and dogs can be infected but
seronegative for years [23]. Various means of serology are
the primary diagnostic tests used for surveillance of visceral
leishmaniasis. For public health surveillance in the US where
this disease is not endemic in humans, testing is performed
via an indirect ﬂuorescent antibody assay (IFA) by the
Centers for Disease Control and Prevention (CDC). IFA is
suﬃcient for screening purposes, but is found to cross react
with antibodies to the kinetoplastid Trypanosoma cruzi. T.
cruziinfectsdogsintheSoutheasternUS,thusfurthertesting
is required to determine parasite speciﬁcity unless clinical
signs are much more consistent with one infection over the
other; for example, cardiomyopathy in the case of Chagas’
disease. Other serologic tests are available in the US for
detection of canine leishmaniasis including a highly sensitive
and specifc kELISA available through the Cornell University
diagnostic laboratory and a K39-antigen based assay avail-
able through Heska. Positive serology in Foxhounds appears
to more closely correlate with the appearance of clinical
disease than incidence of infection. Reports have shown that
qPCR performed by a well-regulated and stringently tested
laboratory can be a more sensitive test for Le. infantum
infection in dogs and can detect asymptomatic dogs and/or
dogs that have not yet to seroconvert [21]. qPCR is available
through Iowa State University and the CDC.
6. IL-10 andPathogenesis of VL
Mechanisms underlying systemic spread of Leishmania
infantum during VL are not well understood. Mammalian
host responses which prevent progression to clinical VL
has been shown to be dependent on promoting T helper-1
IFN-γ production-basedimmunity and parasiticidal activity
within infected macrophages [3]. A key immunological
feature of late stage clinical VL in either humans or
dogs is an inability to proliferate or to produce IFN-
γ in response to Leishmania antigen ([24]a n dP e t e r s e n
preliminary data). Pharmacologically-cured individuals are
resistant to re-infection and mount antigen-speciﬁc IFN-γ
responses in vitro, indicating that there is not an inherent
defect in host CD4+ T cell responses of clinical patients
once they have reached this stage. The actual factors which
inﬂuence clinically-observed infection with Le. infantum
are still mainly speculative [25]. One study of genetic
factors predisposing to clinical VL identiﬁed a TNF-α allele
associated with high serum levels of this cytokine [26].
High levels of TNF-α have been proposed to stimulate
production of regulatory cytokines, speciﬁcally IL-10, as
a homeostatic response to prevent further inﬂammation-
mediated pathology. High leisonal IL-10 mRNA production
is frequently found in human patients with VL [25, 27],
and produced by polysymptomatic Foxhounds (Petersen
preliminary data). IL-10 can be produced by many cell
types including T cells, B cells and macrophages. One of
the proposed mechanisms of IL-10 promotion of VL is by
conditioning macrophages for parasite growth and survival
versus killing. The best means of determining how leisonal
IL-10 contributes to disease outcome would ex vivo study of
splenic cells [27], which is not possible in human patients.
7.Ge neticF act o rsR elat edt oV isc e ral
LeishmaniasisDiseaseSusceptibility
Although several genetic polymorphisms, including alter-
ations in TNF-α and solute carrier family 11A1 (SLC11A1,
formerly NRAMP1) allelic expression, have been indicated
to predispose to disease [26, 28], causative factors of disease
susceptibility in both humans and dogs, speciﬁcally those
associated with heritability, remain elusive. Breed type has
also been shown to alter the response to therapy, suggesting
that canine breed-related genetic factors modulate disease
progression and are therefore prognostically signiﬁcant [29].
Numerous Foxhounds have tested positive for visceral
leishmaniasis in the US and infection appears to be endemic
only within this breed in the US If vertical transmission is
indeed the primary route of transmission in these dogs, a
particular genetic susceptibility is not absolutely necessary
for widespread infection to occur in the Foxhound popu-
lation. Both the observance of visceral leishmaniasis within
speciﬁc families of Foxhounds and ﬁnding hounds that are
Leishmania disease-resistant suggests that it is highly likely
thatparticulargenetictraitsofdogsatleastinpartdetermine
which dogs develop visceral leishmaniasis versus remain
clinically disease-free.
8.Treatment/Prognosis
Treatment of visceral leishmaniasis (VL) is rarely 100%
curative. Prognosis for emaciated chronically infected dogs is
verypoorandinthesecaseseuthanasiashouldbeconsidered.
DuetodiﬃcultyobtainingcertaindrugsintheUnitedStates,
treatment in dogs is recommended to begin with allopurinol
(Zyloric). This drug is eﬃcacious and relatively nontoxic
when used as a maintenance drug. Clinical remission is
often achieved when used alone. Relapses are common4 Interdisciplinary Perspectives on Infectious Diseases
when treatment ceases, complete cures are rare but survival
occurs in 80% of cases over 4 years if renal insuﬃciency
is not present when treatment is initiated. This drug is
sometimes used in combination both in dogs and humans
with pentavalent antimony (Glucantime), as drug resistance
is seen for pentavalent antimony alone in endemic areas
(France, Spain, and Italy). Pentavalent antimonials are not
licensedforuseintheUnitedStatesandcanonlybeobtained
via an investigational drug use protocol from the CDC
[30, 31]. The two main drugs in this class are (1) sodium
stibogluconate (Pentostam, Wellcome Foundation Ltd, UK),
which requires daily injection and has severe side eﬀects, and
(2) meglutamine antimoniate (Glucantime, Pﬁzer/Merial,
France), which has less side eﬀects. Amphotericin B in the
lipid emulsion or liposomal form is relatively nonnephro-
toxic and is eﬀective against the organism, although it is
not thought to be superior to allopurinol as it is still both
more costly and more toxic. Renal insuﬃciency must be
treated prior to giving antimonial drugs or amphotericin B
as prognosis is dependent on renal function at the onset of
treatment. Treatment eﬃcacy is best monitored by clinical
improvement and presence of organisms in biopsy or as
measured by rigorously controlled qPCR. Relapses occur
a few months to a year after therapy, so dogs should be
rechecked at least every 2 months after the end of treatment.
Prognosis for a cure is very guarded, but therapy does
provide infected dogs improved quality of life.
Second-line drugs, which require further clinical studies
to understand their eﬃcacy in both dogs and humans,
include miltefosine (Impavido or Miltex) and paromomycin
(Humantin). Paromymycin has been shown to have fewer
side eﬀects than other drugs in humans. Use of this drug
has been primarily targeted to the cutaneous versions of
Leishmania, less is known about its ability to remove
organ-based infection. There is no eﬀective vaccine against
CVL available in the United States. A secreted parasite
antigen-based vaccine has recently been licensed for use in
dogs in Brazil. Sand ﬂy vector control measures, including
deltamethrin or permethrin-impregnated collars are useful
to date to prevent disease [32]. In many countries, due to the
tie of canine infection to human disease, culling of dogs is
still used as a means to prevent human disease [33, 34].
9. Summary
Factors which contribute to clinical VL are poorly under-
stood. Canine VL mimics both immunology and pathophys-
iology of human disease. Leishmania infantum infection is
endemic in the US Foxhound population. Study of these
naturally infected dogs allows insight into the mechanism
of lesional IL-10 and other host factors in promoting
clinical disease. A cohort population of domestic dogs,
speciﬁcally American Foxhounds, provides a unique and
valuable model system to deﬁne vector and host factors
thatmediatepresentationwithclinicalvisceralleishmaniasis.
Current evidence indicates that nontraditional means of
transmission, particularly vertical transmission, may be a
primary route of transmission of the parasite in US dogs,
although Lutzomyia species in the US may be involved in
transmission.Furtherstudyisnecessarytobetterunderstand
the impact of vertical transmission of leishmaniasis on the
persistence of this disease and determine the likelihood of
vector-borne transmission in the US.
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